Switch to: References

Add citations

You must login to add citations.
  1. Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance.Jonathan Liberman - 2012 - Journal of Law, Medicine and Ethics 40 (2):326-347.
    In her opening address to the 2011 session of the World Health Organization's governing body, the World Health Assembly, WHO's Director-General, Dr. Margaret Chan, noted that WHO's job was much more straightforward when it was dealing mainly with germs, hygiene, medicines, vaccines and sister sectors, like water supply and sanitation. Today, international public health governance is much more complex. It is not only about forging agreement around shared health problems, but also being concerned with health as an outcome of global (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Mitigation/Adaptation and Health: Health Policymaking in the Global Response to Climate Change and Implications for other Upstream Determinants.Lindsay F. Wiley - 2010 - Journal of Law, Medicine and Ethics 38 (3):629-639.
    In coming decades, enhanced global health governance will be crucial to achieving international health and development objectives in the face of a number of challenges; this article focuses on one of them. Climate change, which is now widely recognized as the defining challenge of the 21st century, will make the work of ensuring the conditions in which people can be healthy more difficult in a myriad of ways. Scientists from both the health and climate communities have been highlighting the significant (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Pharmaceutical Knowledge Governance: A Human Rights Perspective.Trudo Lemmens - 2013 - Journal of Law, Medicine and Ethics 41 (1):163-184.
    In recent years, the development process of pharmaceuticals, medical devices, and related products and the overall market of these products have become increasingly global. This paper discusses the need for better governance of one aspect of this market: the production, distribution, and use of pharmaceutical knowledge. Various controversies, some of which will be described in this paper, highlight how industry control over pharmaceutical data production has resulted in very serious threats to public health. Different practices and regulatory fields that affect (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations